Spark Therapeutics plans to file for U.S. regulatory approval next year for the first gene therapy product on the market in the U.S.» Read More
Joe Jimenez, Novartis CEO, discusses the pharma company's quarterly results and its new heart failure drug, Entresto.
A man bitten by a rattlesnake this month says he received a $153,000 hospital bill.
While the initial panic or hysteria may have dissipated, the threat of Ebola remains imminent, survivor Kent Brantly said.
Stocks like Cerner and Illumina will benefit from megatrends in health-care IT, Eaton Vance's Yana Barton told CNBC.
A woman diagnosed with HIV at birth is the longest to survive with no evidence of disease after stopping drug treatment.
Novavax shares rose at Tuesday's market open after the bio-pharmaceutical firm said its Ebola vaccine showed promising early results.
Novartis saw sales fall in Q2, but it's optimistic about its pipeline, particularly heart disease drug Entresto, CEO Joe Jimenez says.
Mad Money's Jim Cramer lays out the case for an urgent Johnson & Johnson breakup.
Jim Cramer makes the case as to why Johnson & Johnson cannot wait another day to break itself up.
About 12 million people claimed they were exempt from the law obligating they have health coverage.
Medicines in development at Biogen and Eli Lilly could be the first to slow the cognitive declines brought by Alzheimer’s disease. How do they work?
Timothy Walbert, Horizon Pharma chairman & CEO, talks about the company's earning providing patients access to drugs, and its bid for Depomed.
Discussing advancements in the effort to find a cure for Alzheimer's, with CNBC's Meg Tirrell and Fred Hassan, Warburg Pincus.
Biogen is looking to settle on one key thing: the perfect dose for its experimental Alzheimer's drug.
Aetna has severed ties with a agent who sold hundreds of heavily subsidized health plans to homeless people.
Most people want Medicare and Medicaid to keep their current structure, despite GOP calls for changes.
New seaweed strain has double the nutrients of kale, and tastes like bacon according to researchers.
Health plans sold on Obamacare exchanges on average have 34 percent fewer hospitals and doctors available than other options.
The Supreme Court’s ruling on Obamacare is a step in the wrong direction for the U.S. government, says this senator.
Existing anti-malaria drugs have the ability to treat Parkinson's disease, a team of international scientists announced on Thursday.
Get the best of CNBC in your inbox